There is no authoritative data to show how long lung sarcomatoid cancer patients can live, the specific survival time of patients is related to the severity of the disease and whether they receive treatment or not, and the 5-year survival rate of most of the lung sarcomatoid cancers is in the range of 10%~33%. The survival time of patients with lung sarcoma-like cancer should be judged according to whether the patient’s lung sarcoma-like cancer has metastasized and whether he/she receives timely and effective treatment. If the patient’s lung sarcomatoid cancer has not metastasized and the patient undergoes timely surgery to remove the lesion and surrounding lymphatic tissues, the 5-year survival rate of the patient can reach 33%. If the patient’s lung sarcomatoid cancer tumor cells have metastasis, the patient’s body is not suitable for surgical treatment, and the patient is not sensitive to radiotherapy and chemotherapy, the patient’s 5-year survival rate is generally 10%~21%. Patients with pulmonary sarcomatoid cancer need to seek medical treatment in time, and doctors will judge the specific survival time according to the patient’s physical condition. It is suggested that patients with pulmonary sarcomatoid cancer can choose appropriate measures of treatment under the guidance of doctors, which is conducive to improving the quality of survival and prolonging the survival time of patients.